Research Topics
Genomes and Genes
Species | Florence PasquierSummaryAffiliation: CHRU de Lille Country: France Publications
| Collaborators
|
Detail Information
Publications
Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer riskKarolien Bettens
Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, 2610 Antwerpen, Belgium
Mol Neurodegener 7:3. 2012....
Diabetes mellitus and dementiaF Pasquier
Department of Neurology, EA 2691, Memory Clinic, Lille, France
Diabetes Metab 32:403-14. 2006..Many interventions could reduce the cognitive decline associated with DM, yet not enough are taken into account so far...
Natural history of frontotemporal dementia: comparison with Alzheimer's diseaseFlorence Pasquier
Memory Clinic, University Hospital, EA 2691, and INSERM U 508, Lille, France
Dement Geriatr Cogn Disord 17:253-7. 2004..Frontotemporal dementia (FTD) is a more common cause of dementia than previously recognised. Few data are available regarding the natural course of FTD in terms of survival, nursing home admission and causes of death...
Laboratory investigations and treatment in frontotemporal dementiaFlorence Pasquier
CHRU Clinique Neurologie, Lille. France
Ann Neurol 54:S32-5. 2003
Memory impairment differs in frontotemporal dementia and Alzheimer's diseaseF Pasquier
Memory Centre, Department of Neurology, University Hospital of Lille, Lille, France
Neurocase 7:161-71. 2001..AD patients with clinical and imaging frontal lobe dysfunction tended to have lower memory performance and to differ even more from FTD patients than AD patients without frontal lobe dysfunction...
Relevance of white matter changes to pre- and poststroke dementiaF Pasquier
Department of Neurology, EA 2691 MENRT, University Hospital of Lille, France
Ann N Y Acad Sci 903:466-9. 2000..White matter changes were also associated with an increased risk of poststroke dementia, 2 years after stroke onset. Thus, white matter changes contribute to dementia occurring in stroke patients...
[Risk factors and mechanisms of post-stroke dementia]F Pasquier
Centre de la Mémoire, Centre Hospitalier et Universitaire de Lille
Rev Neurol (Paris) 155:749-53. 1999..Even when vascular lesions and degenerative changes (mainly Alzheimer changes) are not severe enough, no their own, to be the cause of dementia, their summation may reduce the preclinical stage of the degenerative process...
The clinical picture of frontotemporal dementia: diagnosis and follow-upF Pasquier
Memory Clinic, Centre Hospitalier et Universitaire, Lille, France
Dement Geriatr Cogn Disord 10:10-4. 1999..Behavioural disorders evolved with time but restlessness and hyperorality were long-lasting. Imaging showed the progression of a consistent pattern of anterior abnormalities with frequent leukoaraiosis...
Non-Alzheimer degenerative dementiasF Pasquier
Department of Neurology, Centre Hospitalier et Universitaire, Lille, France
Curr Opin Neurol 11:417-27. 1998..The approach of studying these diseases has changed considerably with genetic and biochemical analyses. A molecular classification is suggested and the clinical significance of this classification is discussed...
Early diagnosis of dementia: neuropsychologyF Pasquier
Department of Neurology, Memory Clinic, Centre Hospitalier Regional et Universitaire, Lille, France
J Neurol 246:6-15. 1999..Moreover, there may be overlap between two or more pathologies, which complicates the diagnostic process. Follow-up of patients is necessary to improve diagnostic accuracy...
Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysisJean Charles Lambert
INSERM U744, Lille, France
J Alzheimers Dis 20:1107-18. 2010..In conclusion, a systematic search for biological pathways using GWAS data set seems to comfort the primary causes already suspected but may specifically highlight the importance of the immune system in AD...
Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's diseaseLouisa Goumidi
INSERM, U744, Lille, France
Neurobiol Aging 32:624-30. 2011..19 [0.97-1.45], p=0.10). The relationship between the genetic variability of the THRA gene and AD risk remains uncertain but cannot be entirely excluded...
Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association studyGeoffroy Laumet
INSERM U744, Lille, France
J Alzheimers Dis 20:1181-8. 2010..Of the genes showing nominal association in our cohorts, TFAM and CHRNB2 appear particularly interesting and warrant further genetic and functional follow-up analyses...
Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer's disease?Franck Hansmannel
INSERM, U744, Institut Pasteur de Lille, Universite de Lille, Lille, France
Neurosci Lett 449:76-80. 2009..19, p=0.004). This association was independent of age and ApoE status. Our results support that the OTC gene may be a minor genetic determinant of AD...
What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?Charlotte Cordonnier
Univ Lille Nord de France, EA 1046, Department of Neurology, Roger Salengro Hospital, F 59000 Lille, France
Brain 133:3281-9. 2010..These findings may contribute to the improvement of prevention and management of patients with intracerebral haemorrhages...
Vascular subcortical hyperintensities predict conversion to vascular and mixed dementia in MCI patientsStephanie Bombois
Department of Neurology, EA 2691, Memory Center, University Hospital 59037 Lille, France
Stroke 39:2046-51. 2008..The aim of our study was to test the hypothesis that subcortical hyperintensities (SH) are associated with an increased rate of conversion to dementia in MCI patients...
Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairmentStephanie Debette
Department of Neurology, Memory Center, Lille University Hospital, Lille, France
Stroke 38:2924-30. 2007..We aimed to test whether cognitive decline is associated with subcortical hyperintensities in patients with mild cognitive impairment (MCI)...
Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's diseaseJulien Chapuis
INSERM, U744, Institut Pasteur de Lille, Universite de Lille 2, Lille, France
Hum Mol Genet 17:2863-7. 2008..In conclusion, these data indicate that the rs760678 SNP of the NEDD9 gene is at best a weak genetic determinant of AD or PD...
Natural history of primary progressive aphasiaEmilie Le Rhun
Department of Neurology, Memory Clinic, University Hospital of Lille, France
Neurology 65:887-91. 2005..The majority of patients with PPA in the current study developed frontotemporal dementia...
Poststroke dementiaDidier Leys
Stroke Department, Department of Neurology, University of Lille II, EA 2691, Rue Emile Laine, Lille, France
Lancet Neurol 4:752-9. 2005..Patients with PSD have high mortality rates and are likely to be functionally impaired. These patients should be treated according to the current guidelines for stroke prevention...
Is the urea cycle involved in Alzheimer's disease?Franck Hansmannel
INSERM U744, Lille, France
J Alzheimers Dis 21:1013-21. 2010..None of the other genes in the pathway appeared to be differentially expressed in the AD brain or act as genetic determinants of the disease...
Study of estrogen receptor-α and receptor-β gene polymorphisms on Alzheimer's diseaseLouisa Goumidi
INSERM, U744 Institut Pasteur de Lille Univ Lille Nord de France UDSL, Lille, France
J Alzheimers Dis 26:431-9. 2011..Our results reinforce the notion that SNPs in the ESR1 or ESR2 genes do not seem to play a major role in the genetic susceptibility of AD...
[Differential diagnosis of Alzheimer's disease]F Pasquier
Clinique Neurologique, Centre Hospitalier et Universitaire, , Lille
Rev Prat 48:1906-11. 1998..Besides, better knowledge on the links between cerebrovascular pathology and Alzheimer's disease, remind us that both pathologies may coexist and should be taken into account...
Depressive symptoms after stroke and relationship with dementia: A three-year follow-up studyA Verdelho
Stroke Department and Memory Clinic, Department of Neurology, University of Lille, Roger Salengro Hospital, Lille, France
Neurology 62:905-11. 2004..CONCLUSION: DS are frequent after stroke. Their time course varies and depends on the cognitive status; this variation contributes to differences among previous studies on poststroke depression...
My belief or yours? Differential theory of mind deficits in frontotemporal dementia and Alzheimer's diseaseRaphaël Le Bouc
Department of Neurology, Universite Lille Nord de France, USLD, CHU Lille, EA 1046, F 59000 Lille, France
Brain 135:3026-38. 2012....
Early epileptic seizures after stroke are associated with increased risk of new-onset dementiaCharlotte Cordonnier
Department of Neurology, University of Lille, Lille, France
J Neurol Neurosurg Psychiatry 78:514-6. 2007..Those lesions in a brain that just experienced a stroke may have lower thresholds for early epileptic seizures. Therefore, epileptic seizures may be a marker of subclinical brain lesions, which may lead to dementia...
Poststroke dementia: influence of hippocampal atrophyMarie-Anne Cordoliani-Mackowiak
Department of Neurology, Stroke Unit, University of Lille, Lille, France
Arch Neurol 60:585-90. 2003..A longer follow-up may be necessary to reevaluate the influence of MTLA...
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillationCatherine Lefebvre
Department of Neurology, University of Lille, Lille, and Department of Neurology, Ste Anne Hospital, Paris, France
Cerebrovasc Dis 21:401-7. 2006..15; 95% CI: 1.48-6.69). CONCLUSION: In daily practice, the under-prescription of OAC in patients with NVAF mainly depends on co-morbidity and on characteristics of the physician, not on prestroke dementia...
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer diseaseA Bruandet
INSERM, U744, Lille, France
J Neurol Neurosurg Psychiatry 80:133-9. 2009..Little is known about the progression of either VaD or AD+CVD. The aim of this study was to compare demographic features, cognitive decline and survival of patients with VaD, AD+CVD and AD alone attending a memory clinic...
Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332SVincent Deramecourt
Univ Lille Nord de France, UDSL, Lille, France
J Alzheimers Dis 31:741-9. 2012..From a clinical point of view, this mutation is associated with considerable intrafamilial phenotypic variation...
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseJean Charles Lambert
INSERM U744, Lille, France
Nat Genet 41:1094-9. 2009..Previous biological studies support roles of CLU and CR1 in the clearance of beta amyloid (Abeta) peptide, the principal constituent of amyloid plaques, which are one of the major brain lesions of individuals with Alzheimer's disease...
Association study of the GAB2 gene with the risk of developing Alzheimer's diseaseJulien Chapuis
INSERM, U744, Institut Pasteur de Lille, Universite de Lille 2, Lille, France
Neurobiol Dis 30:103-6. 2008..3, 95%CI 1.0-1.6, p=0.05) in varepsilon4-carriers. In addition, the rs2373115 did not modulate the extent of tau phosphorylation in the brain of 89 AD cases. The GAB2 gene is at best a minor genetic determinant of AD...
Reasons that prevent the inclusion of Alzheimer's disease patients in clinical trialsAdeline Rollin-Sillaire
Univ Lille Nord de France, UDSL, Lille, France
Br J Clin Pharmacol 75:1089-97. 2013..To assess reasons that prevent Alzheimer's disease (AD) patients from being included in clinical trials...
Phenotype associated with APP duplication in five familiesLucie Cabrejo
Department of Neurology, University Hospital IFRMP, France
Brain 129:2966-76. 2006..A striking feature consisted in intraneuronal Abetax-40 accumulation located in the granular cell layer of the dentate gyrus and in the pyramidal cell layer of the Ammon's horn...
Biomarkers for the early stages of clinical development in Alzheimer's diseaseRegis Bordet
EA 1046, Faculte de Medecine, Universite de Lille II, Département Universitaire de Pharmacologie, Lille, France
Therapie 65:285-90, 277-283. 2010....
An analysis of communication in conversation in patients with dementiaMarc Rousseaux
Université Lille Nord de la France EA 2691 and Institut d Orthophonie, Lille, France
Neuropsychologia 48:3884-90. 2010..FTD patients showed most severe difficulties in PC and verbal and non-verbal pragmatics, in relation to their frontal lesions. AD patients had prominent impairment of lexical-semantic operations...
Bilateral temporal glioma presenting as a paraneoplastic limbic encephalitis with pure cognitive impairmentVincent Deramecourt
Department of Neurology and Memory Clinic, University Hospital of Lille and Lille II University, France
Neurologist 15:208-11. 2009..Clinical and MRI features can mimic paraneoplastic limbic encephalitis (PLE), and the differential diagnosis between these 2 entities may be difficult...
[Treatment of Alzheimer's disease]Stephanie Bombois
centre mémoire de ressource et de recherche, EA 2691, CHRU de Lille, 59037 Lille
Rev Prat 55:1913-9. 2005..However, AD represents a problem of public health and preventive and curative strategies have to be proposed...
Prevalence of risk factors of prion-related disease according to the French circular 138 (DGS/DH/5C/DHOS/E2/2001/138) among patients referred for gastrointestinal endoscopyPhilippe Bulois
Service des Maladies de l Appareil digestif, Hopital Claude Huriez, Urgence Respiratoire et Réanimation Médicale, France
Gastroenterol Clin Biol 29:664-6. 2005..To assess the prevalence of risk factors of prion-related disease transmission in a gastrointestinal endoscopy unit...
Diabetes and cognitive impairment: how to evaluate the cognitive status?F Pasquier
Universite Lille Nord de France, UDSL, EA 1046, CHRU, Hopital Roger Salengro, Lille, France
Diabetes Metab 36:S100-5. 2010..They also have an elevated risk of both vascular dementia and Alzheimer's disease. Cognitive impairment may have consequence on treatment compliance...
Is there a typical pattern of brain SPECT imaging in Alzheimer's disease?M Steinling
Brain Functional Imaging Unit, University Hospital, CHRU de Lille, Faculte de Medecine, Universite de Lille II, F 59037 Lille Cedex, France
Dement Geriatr Cogn Disord 12:371-8. 2001..We hypothesise that the major simplification concerning the pattern observed in AD can be explained by the fact that patients suffering from LBD have previously been included in the groups of AD patients...
[Arterial hypertension and cognitive decline]D Leys
Service de neurologie et pathologie neurovasculaire, Hopital Roger Salengro
Rev Neurol (Paris) 155:743-8. 1999..Preliminary results obtained in elderly subjects with systolic arterial hypertension, support this hypothesis...
[Dementia following bipolar disorder]F Lebert
EA2691, centre de la mémoire de ressources et de recherche, Hopital R Salengro, CHRU de Lille, Lille, France
Encephale 34:606-10. 2008..In old age BPD, the cognitive decline is more severe and can fulfill the criteria of dementia. However, the characteristics of bipolar disorder dementia are still unknown...
Poststroke dementia: incidence and relationship to prestroke cognitive declineH Henon
Department of Neurology, Stroke Unit, University of Lille, France
Neurology 57:1216-22. 2001..To evaluate the 3-year incidence of poststroke dementia (PSD) and the influence of prestroke cognitive decline...
White matter changes and poststroke dementiaD Leys
Department pf Neurology, University of Lille, France
Dement Geriatr Cogn Disord 9:25-9. 1998....
Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT dataP Charpentier
Department of Neurology, Roger Salengro Hospital, Regional and Universitary Hospital, 59037 Lille Cx, France
J Neurol Neurosurg Psychiatry 69:661-3. 2000....
Epidemiology of vascular dementiaD Leys
Department of Neurology, Stroke and Memory Centers, University of Lille, France
Haemostasis 28:134-50. 1998..However, white matter changes, and associated Alzheimer pathology, which are both frequent in this age category, may also contribute to the cognitive decline...
[Classification of parkinsonian syndromes via factorial discriminant analysis of brain SPECT data]A Kreisler
EA 2683, Service de Neurologie et Pathologie du Mouvement, Hopital Roger Salengro, CHU de Lille, 59037 Lille Cedex, France
Rev Neurol (Paris) 165:440-8. 2009....
Leukoaraiosis more than dementia is a predictor of stroke recurrenceH Henon
Department of Neurology, Stroke Unit, Memory Clinic, University of Lille, Lille, France
Stroke 34:2935-40. 2003..Our aim was to determine the influence of prestroke and poststroke dementia on the 3-year risk of stroke recurrence...
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's diseaseI Masse
Department of Neurology, University Hospital, 59037 Lille, France
J Neurol Neurosurg Psychiatry 76:1624-9. 2005..002). CONCLUSIONS: LLAs may slow cognitive decline in Alzheimer's disease and have a neuroprotective effect. This should be confirmed by placebo controlled randomised trials in patients with Alzheimer's disease and no dyslipaemia...
Prediction of pathology in primary progressive language and speech disordersV Deramecourt
Memory Clinic, EA 2691, CHRU Lille F 59037 Lille, France
Neurology 74:42-9. 2010..This study sought to characterize correlations between 1) the different clinical variants of primary progressive language and speech disorders and 2) the pathologic diagnosis...
Sleep disorders in aging and dementiaS Bombois
Center for Memory Resources and Research, EA2691, Lille University Hospital, University of Lille Nord de France, Lille Cedex, France
J Nutr Health Aging 14:212-7. 2010..In healthy but frail elderly people and in early-stage AD patients, sleep should be more thoroughly characterized (notably by using standardized interviews and polysomnographic recording)...
Contribution of single photon emission computed tomography to the differential diagnosis of dementia in a memory clinicAdeline Rollin-Sillaire
EA 1046, Memory Clinic, Univ Lille Nord de France, UDSL, CHU, Lille, France
J Alzheimers Dis 30:833-45. 2012..For AD and FTLD/PSP/CBDs, agreement between the clinical and SPECT-based diagnoses was always confirmed by neuropathological assessment...
Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart diseaseMarie Girot
Department of Neurology, University of Lille, Roger Salengro Hospital, 59037, Lille, France
J Neurol 251:529-36. 2004..CONCLUSION: Many patients were not properly treated in both groups, and differences between practice and guidelines were more frequent in the CHD group, where guidelines are more strict...
Poststroke dementia in the elderlyMarie Anne Mackowiak-Cordoliani
Department of Neurology, Memory Clinic, University Hospital, Lille, France
Drugs Aging 22:483-93. 2005..Better knowledge of the risk factors for PSD, including environmental and genetic factors, should increase the effectiveness of preventive strategies in patients with this condition...
Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementiaStephanie Bombois
Department of Neurology, Resource and Research Memory Center, University Hospital, Lille, France
Arch Neurol 64:583-7. 2007....
Frontotemporal dementia: a randomised, controlled trial with trazodoneFlorence Lebert
Memory Clinic, Lille University Hospital, Lille, France
Dement Geriatr Cogn Disord 17:355-9. 2004..The Mini-Mental State Examination was not modified and trazodone was well tolerated. Results of this first placebo-controlled trial suggest that trazodone is an effective treatment for the behavioural symptoms of FTD...
Rapid categorization of faces and objects in a patient with impaired object recognitionMuriel Boucart
LNFP, Universite Lille Nord de France, CNRS, Lille, France
Neurocase 16:157-68. 2010..Displaying pictures in isolation did not improve performance. The results suggest that rapid categorization can be accomplished on the basis of coarse information without overt recognition...
Prevalence and determinants of cognitive impairment in chronic heart failure patientsStephanie Debette
Department of Cardiology, University Hospital of Lille, Lille, France
Congest Heart Fail 13:205-8. 2007..The severity of cognitive impairment parallels that of CHF. The question of whether this cognitive impairment decreases adherence to treatment and contributes to a worse outcome in CHF patients should be explored...
Different patterns of Mini Mental Status Examination responses in primary progressive aphasia and Alzheimer's diseaseE Le Rhun
Department of Neurology, Research and Resource Memory Centre and EA 2691, University Hospital of Lille, Lille, France
Eur J Neurol 13:1124-7. 2006..Our findings indicate that the various MMSE item scores may be helpful in differentiating PPA and AD in the first few years of the disease...
Perception of emotion on faces in frontotemporal dementia and Alzheimer's disease: a longitudinal studyI Lavenu
Memory Disorders Unit, Department of Neurology, University Hospital of Lille, EA 2691, Lille, France
Dement Geriatr Cogn Disord 19:37-41. 2005..Inconsistency of the results in FTD may be related to impulsiveness, lack of consistency of the patients and to heterogeneity of the progression of the lesions...
Cognitive decline and survival in Alzheimer's disease according to education levelA Bruandet
INSERM, U744, Institut Pasteur de Lille, Universite de Lille 2, Lille, France
Dement Geriatr Cogn Disord 25:74-80. 2008..We tested the hypothesis that a higher education level is associated with faster cognitive decline and lower survival in a cohort of 670 Alzheimer's disease patients, followed for 3.5 years at the Lille-Bailleul memory centre...
Action and noun fluency testing to distinguish between Alzheimer's disease and dementia with Lewy bodiesXavier Delbeuck
Centre Memoire de Ressources et de Recherche, EA 1046, Universite Lille Nord de France, Lille, France
J Clin Exp Neuropsychol 35:259-68. 2013..However, a composite action and animal fluency score was found to be more effective for discriminating between these two groups...
Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain diseaseClaude-Alain Maurage
INSERM U422, , , 1 place de Verdun, 59045 Cedex, Lille, France
Acta Neuropathol (Berl) 106:575-83. 2003..We suggest that "diffuse" AGD might be a subgroup of AGD, the specific profile of which is different from that of "limbic" AGD...
[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]Luc Buee
INSERM U837, Place de Verdun, Lille, France
Therapie 65:401-7. 2010..Until now, mainly amyloid pathology has been targeted un many clinical trials without any success. Both new therapeutic strategies and diagnosis improvement are needed...
[Frontotemporal dementia: behavioral story of a neurological disease]Florence Lebert
Centre de la Mémoire, Hopital Salengro, CHRU de Lille, France
Psychol Neuropsychiatr Vieil 6:33-41. 2008..However, over time, the occurrence of mutism may lead caregivers to regret the period of behavioral disorders...
Influence of prestroke dementia on early and delayed mortality in stroke patientsHilde Henon
Department of Neurology, Hopital Roger Salengro, CHRU of Lille, 59037 Lille, France
J Neurol 250:10-6. 2003..Dementia adversely influences vital outcome in stroke patients, perhaps partly because the therapeutic approach differs between demented and non-demented patients...
Influence of pre-existing dementia on the risk of post-stroke epileptic seizuresC Cordonnier
Department of Neurology, Stroke Unit, , F-59037 Lille, France
J Neurol Neurosurg Psychiatry 76:1649-53. 2005..34 to 16.21). CONCLUSION: Stroke patients with pre-existing dementia have an increased risk of late seizures. Any factor increasing the risk of seizures (drugs, metabolic changes) should be avoided in these patients...
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodiesV Deramecourt
Inserm Unit 815, Lille, France
J Neuropathol Exp Neurol 65:278-88. 2006..The constant and abundant Abeta x-42 deposition in sporadic DLB suggests that synucleinopathy is also promoted by APP dysfunction. Therefore, we conclude that APP is a therapeutic target for both AD and DLB...
Tacrine efficacy in Lewy body dementiaF Lebert
Memory Clinic, Centre Hospitalier Universitaire and Faculté de Médecine, Lille, France
Int J Geriatr Psychiatry 13:516-9. 1998..Response to tacrine varies among patients with Alzheimer's disease (AD). Lewy body dementia (LBD) could be a high responder subtype of AD. The aim of the study was to compare the effects of tacrine in LBD and AD...
Influence of cognitive impairment on the institutionalisation rate 3 years after a strokeM Pasquini
Department of Neurology Stroke Unit, Lille University Hospital, Lille, France
J Neurol Neurosurg Psychiatry 78:56-9. 2007..Pre-existing cognitive decline and new-onset dementia are common in patients with stroke, but their influence on institutionalisation rates is unknown...
Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?Florence Richard
INSERM U744, Lille, France Université de Lille Nord de France, Lille, France Lille University Hospital, Lille, France Institut Pasteur de Lille, Lille, France Excellence Laboratory DISTALZ, Lille, France
J Alzheimers Dis 32:765-72. 2012..In the present article, we review the potential value of managing hypertension, diabetes, hypercholesterolemia or global vascular risk factors in AD patients...
Contribution of APOE promoter polymorphisms to Alzheimer's disease riskJ C Lambert
INSERM U508, Institut Pasteur de Lille, Lille, France
Neurology 59:59-66. 2002..To determine whether the effects of APOE promoter polymorphisms on AD are independent of the APOE-epsilon4 allele...
Poststroke dementiaH Henon
Department of Neurology, Stroke Unit, Lille University Hospital, Lille, France
Cerebrovasc Dis 22:61-70. 2006..The influence of stroke location, vascular risk factors and silent infarcts remains to be determined. PSD adversely influences the outcome in stroke patients...
Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcomeF Corea
Department of Neurology, Stroke Unit, University of Lille, Roger Salengro Hospital, 59037 Lille, France
J Neurol 248:271-8. 2001..66, 95% CI 1.22-5.79). SI did not affect vital or functional outcome or the occurrence of new vascular events within 2 years after stroke. Whether they affect cognitive outcome remains under evaluation over a longer follow-up period...
Long-term outcome of acute and subacute myelopathiesS Debette
Department of Neurology, University Hospital of Lille, Hopital Roger Salengro, CHRU de Lille, 59037, Lille, France
J Neurol 256:980-8. 2009..Finally, a long-term follow-up is important given the large number of causes that are identified at a distance from the initial event...
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's diseaseF Bensemain
INSERM, U744, Institut Pasteur de Lille, Universite de Lille 2, Lille, France
Mol Psychiatry 14:106-16. 2009..In conclusion, our results suggest the involvement of a new pathway in AD brains involving the urea cycle...
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label studyKeith Edwards
Alzheimer s Diagnostic and Treatment Center, Bennington, VT 05201, USA
Dement Geriatr Cogn Disord 23:401-5. 2007..Dementia with Lewy bodies (DLB) is a common dementia of the elderly. A significant cholinergic deficit has been demonstrated that may be responsive to treatment by cholinesterase inhibitors (ChEIs)...
Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patientsJean Sébastien Vidal
Institut National de la Santé et de la Recherche Médicale INSERM U708, Paris, France
Alzheimer Dis Assoc Disord 22:125-30. 2008..Approximately one-third of the memantine-treated patients did not strictly fit with the French summary of product characteristic recommendations for the first memantine prescription...
Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypesStephanie Bombois
Stroke 38:2595-7. 2007..We sought to describe their frequency and distribution, and to test their association with cognitive characteristics in MCI patients...
[Epidemiology of Alzheimer disease and related disorders]Catherine Helmer
INSERM U.593, , 146, , 33076 Bordeaux Cedex, France
Med Sci (Paris) 22:288-96. 2006..Four ways of prevention are credible. The most important is the treatment of vascular risk factors and particularly hypertension. Other ways are nutritional factors, stimulating leisure activities and depression...
Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic studyIsabelle Le Ber
1INSERM, UMR_S679 Neurologie and Thérapeutique Expérimentale, F 75013, Paris, France
Brain 131:732-46. 2008..Since all the mutations cause a progranulin haploinsufficiency, additional factors probably explain the variable clinical presentation of the disease...
The dynamic time course of semantic memory impairment in Alzheimer's disease: clues from hyperpriming and hypopriming effectsBénédicte Giffard
Inserm E0218 Université de Caen, Laboratoire de Neuropsychologie, CHU Cote de Nacre, 14033 Caen Cedex, France
Brain 125:2044-57. 2002..The data reveal in an astonishing yet striking manner the dynamic semantic memory degradation in Alzheimer's disease through the apparently paradoxical semantic priming effects...
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease riskUte Dreses-Werringloer
Litwin Zucker Research Center for the Study of Alzheimer s Disease, The Feinstein Institute for Medical Research, North Shore LIJ, Manhasset, NY 11030, USA
Cell 133:1149-61. 2008..We propose that CALHM1 encodes an essential component of a previously uncharacterized cerebral Ca(2+) channel that controls Abeta levels and susceptibility to late-onset AD...
Biochemistry of Tau in Alzheimer's disease and related neurological disordersNicolas Sergeant
INSERM, U837, Place de Verdun, 59045 Lille, France
Expert Rev Proteomics 5:207-24. 2008..Finally, recent advances in proteomics technology are essential to develop further therapeutic targets and early predictive and discriminative diagnostic assays for Alzheimer's disease and related disorders...
Tau aggregation in the hippocampal formation: an ageing or a pathological process?Andre Delacourte
Unite INSERM 422, 1, Place de Verdun, 59045 Lille Cedex, France
Exp Gerontol 37:1291-6. 2002..Tauopathy in the entorhinal and hippocampal formation could be another type of pathological dysfunction of tau proteins, and a therapeutic target to delay AD. Relevant animal models are desperately needed to address this issue...
Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degenerationGiovanni Stevanin
1INSERM, U679, Universite Pierre et Marie Curie Paris 6, UMR S679, Paris, France
Brain 131:772-84. 2008..In conclusion, our study reveals the high frequency of SPG11 mutations in patients with HSP, a TCC and cognitive impairment, including in isolated patients, and extends the associated phenotype...
Central and peripheral agraphia in Alzheimer's disease: from the case of Auguste D. to a cognitive neuropsychology approachJany Lambert
Inserm EPHE Universite de Caen Basse Normandie, Unité E0218, Caen, France
Cortex 43:935-51. 2007..Rather, it points to heterogeneous profiles of agraphia and suggests that the first signs of writing impairment in AD stem from changes at different points in the broad anatomical network subserving spelling and writing abilities...
Editorial comment--not all hypertensive subjects have similar risks for white matter lesions: influence of genetic factorsDidier Leys
Stroke 35:1061-2. 2004
Patients characteristics with cholinesterase inhibitor resistant hallucinations in dementia with Lewy bodiesFlorence Lebert
J Neurol Neurosurg Psychiatry 78:1415-6. 2007
Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's diseaseClaire Marie Dhaenens
Groupe Vieillissement Cérébral et Maladies Neurodégénératives, INSERM U422, Laboratoire G Biserte et Faculté de Médecine, Universite de Lille 2, Place de Verdun 59045, Lille Cedex, France
Neurosci Lett 368:290-2. 2004..73, 95% CI: 1.12-2.67, P = 0.012). No synergistic effects were found between the APOE epsilon 4 allele and KNS2 gene polymorphisms...
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteriaBruno Dubois
INSERM U610, Hopital de la Salpetriere, Paris, France
Lancet Neurol 6:734-46. 2007..Validation studies in existing and prospective cohorts are needed to advance these criteria and optimise their sensitivity, specificity, and accuracy...
Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson diseaseAnne Rovelet-Lecrux
INSERM U 614, Faculty of Medicine, Institute for Biomedical Research, 76000 Rouen, France
Neurobiol Dis 31:41-5. 2008..This observation provides a final argument that PGRN mutations exert their pathogenic effect through haploinsufficiency and underlines the diversity of clinical presentations associated with these PGRN alterations...
